| Name | Title | Contact Details |
|---|
Onslow Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Onslow Memorial Hospital is based in Jacksonville, NC. You can find more information on Onslow Memorial Hospital at www.onslowmemorial.org
http://www.pinterest.com/infinitetherap/boards/
More commonly known as Columbia County Health System and Dayton General Hospital, the Columbia County Public Hospital District #1 was established in 1960 with the vision and mission of providing high quality healthcare to our local communities. We are a 25-bed, Critical Access Hospital with Level V Trauma Center, Level III Cardiac and Stroke Center designations. Additionally, we are the regions primary wound care and hyperbaric therapy treatment center. Our primary service areas include Dayton, Waitsburg, Starbuck, and the surrounding region. We are comprised of Columbia Family Clinic, Waitsburg Clinic, Booker Rest Home, and Dayton General Hospital with our Rural Health Clinics open for primary care and behavior health services 6 days a week. We are fully staffed with 3 primary care medical doctors, a board-certified emergency medicine doctor, a board-certified pediatrician, 4 mid-level family practice providers, and dermatology focused ARNP. Our Emergency Department is staffed with our employed providers as well as partner physicians. In addition to Acute Care services, we offer inpatient care for sub-acute, Swing Bed patients, which are patients that need a step down from acute care, but still require skilled nursing care and/or various rehabilitation therapies for an extended period. This service allows patients, who may have had a qualifying, Acute hospitalization or surgery, to return to our facility and receive hospital class nursing and rehabilitation services for an extended period.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Life Center Organ Donor Ntwrk is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.